| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-234-10 | 68083-234 | HUMAN PRESCRIPTION DRUG | Etomidate | Etomidate Injection | SOLUTION | INTRAVENOUS | 20170520 | N/A | ANDA | ANDA209058 | Gland Pharma Limited | ETOMIDATE | 2 mg/mL | 10 VIAL in 1 CARTON (68083-234-10) / 10 mL in 1 VIAL (68083-234-01) |
| 68083-235-10 | 68083-235 | HUMAN PRESCRIPTION DRUG | Etomidate | Etomidate Injection | SOLUTION | INTRAVENOUS | 20170520 | N/A | ANDA | ANDA209058 | Gland Pharma Limited | ETOMIDATE | 2 mg/mL | 10 VIAL in 1 CARTON (68083-235-10) / 20 mL in 1 VIAL (68083-235-01) |
| 72266-147-10 | 72266-147 | HUMAN PRESCRIPTION DRUG | Etomidate | Etomidate Injection | SOLUTION | INTRAVENOUS | 20190903 | N/A | ANDA | ANDA209058 | Fosun Pharma USA Inc | ETOMIDATE | 2 mg/mL | 10 VIAL in 1 CARTON (72266-147-10) / 20 mL in 1 VIAL (72266-147-01) |
| 72266-146-10 | 72266-146 | HUMAN PRESCRIPTION DRUG | Etomidate | Etomidate Injection | SOLUTION | INTRAVENOUS | 20190903 | N/A | ANDA | ANDA209058 | Fosun Pharma USA Inc | ETOMIDATE | 2 mg/mL | 10 VIAL in 1 CARTON (72266-146-10) / 10 mL in 1 VIAL (72266-146-01) |